↓ Skip to main content

Computational Protein Design

Overview of attention for book
Cover of 'Computational Protein Design'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 The Framework of Computational Protein Design.
  3. Altmetric Badge
    Chapter 2 Achievements and Challenges in Computational Protein Design.
  4. Altmetric Badge
    Chapter 3 Production of Computationally Designed Small Soluble- and Membrane-Proteins: Cloning, Expression, and Purification.
  5. Altmetric Badge
    Chapter 4 Deterministic Search Methods for Computational Protein Design.
  6. Altmetric Badge
    Chapter 5 Geometric Potentials for Computational Protein Sequence Design.
  7. Altmetric Badge
    Chapter 6 Modeling Binding Affinity of Pathological Mutations for Computational Protein Design.
  8. Altmetric Badge
    Chapter 7 Multistate Computational Protein Design with Backbone Ensembles.
  9. Altmetric Badge
    Chapter 8 Integration of Molecular Dynamics Based Predictions into the Optimization of De Novo Protein Designs: Limitations and Benefits.
  10. Altmetric Badge
    Chapter 9 Applications of Normal Mode Analysis Methods in Computational Protein Design.
  11. Altmetric Badge
    Chapter 10 Computational Protein Design Under a Given Backbone Structure with the ABACUS Statistical Energy Function.
  12. Altmetric Badge
    Chapter 11 Computational Protein Design Through Grafting and Stabilization.
  13. Altmetric Badge
    Chapter 12 An Evolution-Based Approach to De Novo Protein Design.
  14. Altmetric Badge
    Chapter 13 Parallel Computational Protein Design.
  15. Altmetric Badge
    Chapter 14 Computational Protein Design
  16. Altmetric Badge
    Chapter 15 OSPREY Predicts Resistance Mutations Using Positive and Negative Computational Protein Design.
  17. Altmetric Badge
    Chapter 16 Evolution-Inspired Computational Design of Symmetric Proteins.
  18. Altmetric Badge
    Chapter 17 A Protocol for the Design of Protein and Peptide Nanostructure Self-Assemblies Exploiting Synthetic Amino Acids.
  19. Altmetric Badge
    Chapter 18 Probing Oligomerized Conformations of Defensin in the Membrane.
  20. Altmetric Badge
    Chapter 19 Computational Design of Ligand Binding Proteins.
  21. Altmetric Badge
    Chapter 20 EpiSweep: Computationally Driven Reengineering of Therapeutic Proteins to Reduce Immunogenicity While Maintaining Function.
  22. Altmetric Badge
    Chapter 21 Computational Tools for Aiding Rational Antibody Design.
  23. Altmetric Badge
    Chapter 22 Computational Design of Membrane Curvature-Sensing Peptides.
  24. Altmetric Badge
    Chapter 23 Computational Tools for Allosteric Drug Discovery: Site Identification and Focus Library Design.
Attention for Chapter 20: EpiSweep: Computationally Driven Reengineering of Therapeutic Proteins to Reduce Immunogenicity While Maintaining Function.
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
52 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
EpiSweep: Computationally Driven Reengineering of Therapeutic Proteins to Reduce Immunogenicity While Maintaining Function.
Chapter number 20
Book title
Computational Protein Design
Published in
Methods in molecular biology, January 2017
DOI 10.1007/978-1-4939-6637-0_20
Pubmed ID
Book ISBNs
978-1-4939-6635-6, 978-1-4939-6637-0
Authors

Yoonjoo Choi, Deeptak Verma, Karl E. Griswold, Chris Bailey-Kellogg, Choi, Yoonjoo, Verma, Deeptak, Griswold, Karl E., Bailey-Kellogg, Chris

Editors

Ilan Samish

Abstract

Therapeutic proteins are yielding ever more advanced and efficacious new drugs, but the biological origins of these highly effective therapeutics render them subject to immune surveillance within the patient's body. When recognized by the immune system as a foreign agent, protein drugs elicit a coordinated response that can manifest a range of clinical complications including rapid drug clearance, loss of functionality and efficacy, delayed infusion-like allergic reactions, more serious anaphylactic shock, and even induced auto-immunity. It is thus often necessary to deimmunize an exogenous protein in order to enable its clinical application; critically, the deimmunization process must also maintain the desired therapeutic activity.To meet the growing need for effective, efficient, and broadly applicable protein deimmunization technologies, we have developed the EpiSweep suite of protein design algorithms. EpiSweep seamlessly integrates computational prediction of immunogenic T cell epitopes with sequence- or structure-based assessment of the impacts of mutations on protein stability and function, in order to select combinations of mutations that make Pareto optimal trade-offs between the competing goals of low immunogenicity and high-level function. The methods are applicable both to the design of individual functionally deimmunized variants as well as the design of combinatorial libraries enriched in functionally deimmunized variants. After validating EpiSweep in a series of retrospective case studies providing comparisons to conventional approaches to T cell epitope deletion, we have experimentally demonstrated it to be highly effective in prospective application to deimmunization of a number of different therapeutic candidates. We conclude that our broadly applicable computational protein design algorithms guide the engineer towards the most promising deimmunized therapeutic candidates, and thereby have the potential to accelerate development of new protein drugs by shortening time frames and improving hit rates.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 52 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 21%
Student > Ph. D. Student 9 17%
Student > Bachelor 7 13%
Professor > Associate Professor 5 10%
Other 3 6%
Other 9 17%
Unknown 8 15%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 13 25%
Agricultural and Biological Sciences 8 15%
Immunology and Microbiology 4 8%
Chemical Engineering 3 6%
Engineering 3 6%
Other 9 17%
Unknown 12 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 May 2021.
All research outputs
#7,494,138
of 22,908,162 outputs
Outputs from Methods in molecular biology
#2,328
of 13,132 outputs
Outputs of similar age
#141,111
of 420,477 outputs
Outputs of similar age from Methods in molecular biology
#246
of 1,074 outputs
Altmetric has tracked 22,908,162 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 13,132 research outputs from this source. They receive a mean Attention Score of 3.4. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 420,477 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 1,074 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.